Content
Nokia: Call On The Fallen Angel
Article By:
MoneyShow.com
Read
Saturday, September 11, 2021 3:14 PM EDT
Blue chip companies that stumbled badly — and are starting to recover — are still the best values available to investors today. Nokia is a new addition to our list of fallen angels. It has great potential that I think you should consider.
In this article: NOK
This “Hold Forever” Big-Cap Stock Is Easier Than Ever To Own
Article By:
Shah Gilani
Read
Saturday, September 11, 2021 2:44 PM EDT
I'm going to name one company everyone should buy today and never, ever sell. The thing is, a lot of regular investors I've spoken with think this stock is out of reach to all but the elite. I'm here to tell you that's not the case.
In this article: AMZN
USD/JPY Weekly Forecast: Technical Bears Barred By Strong USD At 110
Article By:
Yohay Elam
Read
Saturday, September 11, 2021 2:30 PM EDT
The USD/JPY forecast is looking neutral to bullish as the Fed’s hawkishness may support the US dollar, while the yen may weaken further amid the COVID-19 spread and political crisis. The USD/JPY pair has been stuck in the range of around 110.00.
Dogecoin's Climb To $1 By Year-End: A Possibility Or A Pipedream?
Article By:
Benzinga
Read
Saturday, September 11, 2021 2:15 PM EDT
Dogecoin has been one of the most volatile assets this year, going to an all-time high of 73.76 cents in early May from 0.47 cents at the end of last year. From the all-time high hit on May 8, the meme currency has come back significantly.
The In-Between Week
Article By:
Marc Chandler
Read
Saturday, September 11, 2021 1:59 PM EDT
The US employment data and the ECB meeting are behind us, and the Federal Reserve, Bank of Japan, Bank of England, and Norway's Norges Bank lie ahead.
Bristol-Myers Squibb: #1 In Big Pharma
Article By:
MoneyShow.com
Read
Saturday, September 11, 2021 1:45 PM EDT
In our review of big pharma stocks, Bristol-Myers Squibb is our top rated stock, with a five-year annual expected return of 14.0%. The company is a leading drug maker of cardiovascular therapeutics, with annual revenues of about $42 billion.
In this article: BMY
Week In Review: Sanofi Acquires Kadmon, A US-China Pharma, For $1.9 Billion
Article By:
ChinaBio® Today
Read
Saturday, September 11, 2021 1:30 PM EDT
France's Sanofi will acquire Kadmon Holdings of New York City in a $1.9 billion deal. In 2019, Kadmon formed a JV with BioNova Pharma to develop its novel lead drug, Rezurock (belumosudil) in China.
Stock Market & Economy Recap - Saturday, Sept. 11
Article By:
Michael Gouvalaris
Read
Saturday, September 11, 2021 1:14 PM EDT
It was a holiday-shortened week with little earnings and economic data, and investors used the opportunity to take some profits. Perhaps the biggest news of the week was the ECB announcement that they would begin reducing its asset purchase program.
In this article: SPX
US Dollar Outlook Hinges On Inflation Report Amid Fed Blackout Period
Article By:
David Song
Read
Saturday, September 11, 2021 12:58 PM EDT
The update to the US Consumer Price Index (CPI) is likely to sway the US dollar during the Federal Reserve’s blackout period as the central bank braces for a transitory rise in inflation.
In this article: UUP
The Great Lockdown: Could This Cause The Worst Economic Downturn Since The Great Depression?
Video By:
David Morgan
Watch
Saturday, September 11, 2021 12:45 PM EDT
The Great Depression was the worst economic downturn in the history of the industrialized world. Could we expect something similar now?
The Return Of Stagflation
Article By:
John Mauldin
Read
Saturday, September 11, 2021 12:30 PM EDT
This year’s economy is built on top of last year’s, which was on top of the year before, and on back. Nothing, not even COVID-19, wipes out the past. We keep feeling its effects. So before we talk about future growth, let’s look back.
In this article: SPX
Technical Market Report For Saturday, Sept. 11
China’s Weak Loan Growth Came From Policy Hit
Article By:
ING Economics
Read
Saturday, September 11, 2021 11:32 AM EDT
Loan growth was still weak in August, which is not associated with historic seasonality. The policy clampdown has hit businesses. The 14th Five Year Plan could help businesses to reorganize their business plans.
Consumer Economic Forecast 2022-23: Supply Will Limit Spending
Article By:
Bill Conerly
Read
Saturday, September 11, 2021 11:05 AM EDT
Consumers will spend more in 2022, thanks to both their own earnings and generous cash given to them by the government in 2020 and 2021.